Back to Search
Start Over
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium.
- Source :
-
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2022 Nov 28; Vol. 15 (22), pp. 2253-2265. - Publication Year :
- 2022
-
Abstract
- Background: The long-term prognostic implication of platelet reactivity after percutaneous coronary intervention (PCI) is not clearly known.<br />Objectives: The impacts of platelet reactivity from the PTRG-DES consortium were assessed.<br />Methods: The primary endpoint was the major adverse cardiac and cerebrovascular events (MACCE) including all-cause death, myocardial infarction, stent thrombosis, or stroke. Key secondary endpoints were all-cause mortality, major bleeding, and net adverse clinical events (NACE), including MACCE and bleeding.<br />Results: Between 2003 and 2018, a total of 11,714 patients were enrolled and grouped into tertiles according to P2Y <subscript>12</subscript> reaction units (PRUs): high PRUs (≥253), intermediate PRUs (188-252), and low PRUs (<188). The Kaplan-Meier (KM) estimates of the primary outcome were significantly different across the groups; the high-PRU group showed the highest MACCE rate at 5 years (12.9%, 11.1%, and 7.0% in high-, intermediate-, and low-PRU groups, respectively; P < 0.001), as well as at 1 year (P < 0.001). The high-PRU group had the greatest KM estimates of all-cause death (8.2%, 5.9%, and 3.7%, respectively; P < 0.001) at 5 years without significant differences of major bleeding, and resultant of a higher KM estimates of NACE (15.7%, 13.6%, and 9.7%, respectively; P < 0.001). A PRU ≥252, the best cutoff value, was strongly related to MACCE (HR: 1.39; 95% CI: 1.11-1.74; P = 0.003) and all-cause death at 5 years after PCI (HR: 1.42; 95% CI: 1.04-1.94; P = 0.026). The optimal cutoff value of aspirin reaction units predicting the MACCE occurrence was ≥414 and was significantly associated with 5-year MACCE occurrence or all-cause death (P < 0.001).<br />Conclusions: In this large-scale cohort, high PRU was significantly associated with occurrence of MACCE, all-death death, and NACE at 5 years, as well as 1 year after PCI. (PTRG-DES Consortium [PTRG]; NCT04734028).<br />Competing Interests: Funding Support and Author Disclosures The study was designed by the principal investigator and executive committee and was sponsored by the Korean Society of Intervention Cardiology. The funder had no role in study design, data collection, analyses, data interpretation, or preparing the manuscript. Dr Jeong has received honoraria for lectures from AstraZeneca, Daiichi-Sankyo, Sanofi, Han-mi Pharmaceuticals, and Yuhan Pharmaceuticals; and has received research grants or support from Yuhan Pharmaceuticals and U&I Corporation. Dr Joo has received honoraria for lectures from AstraZeneca, Han-mi Pharmaceuticals, Samjin, Dong-A, HK inno.N Pharmaceuticals, and DIO Medical. Dr Song has received honoraria for lectures from AstraZeneca, Daiichi-Sankyo, Sanofi, Bayer Korea, and Samjin Pharmaceutical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.<br /> (Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1876-7605
- Volume :
- 15
- Issue :
- 22
- Database :
- MEDLINE
- Journal :
- JACC. Cardiovascular interventions
- Publication Type :
- Academic Journal
- Accession number :
- 36423968
- Full Text :
- https://doi.org/10.1016/j.jcin.2022.09.007